These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 24695513)

  • 1. Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory Study.
    Bernardes CM; Clark PJ; Brown C; Stuart K; Pratt G; Toombs M; Hartel G; Powell EE; Valery PC
    Patient Prefer Adherence; 2021; 15():2649-2658. PubMed ID: 34853510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for collaboration to improve cardiovascular outcomes in patients with CKD.
    Middleton JP; Patel UD
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):456-9. PubMed ID: 25443570
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic kidney disease and cardiovascular disease.
    Bondugulapati LN; Shandilya S
    Curr Opin Lipidol; 2015 Aug; 26(4):353-4. PubMed ID: 26164730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic kidney disease--update 2014].
    Wanner C; Ketteler M
    Dtsch Med Wochenschr; 2014 Feb; 139(6):261-3. PubMed ID: 24473844
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic kidney disease, diabetes mellitus and cardiovascular disease: risks and commonalities.
    Suckling R; Gallagher H
    J Ren Care; 2012 Feb; 38 Suppl 1():4-11. PubMed ID: 22348359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex care: treating an older patient with multiple comorbidities.
    Ramaswamy R
    Am Fam Physician; 2014 Mar; 89(5):392-4. PubMed ID: 24695513
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel combined management approaches to patients with diabetes, chronic kidney disease and cardiovascular disease.
    Spaak J
    J R Coll Physicians Edinb; 2017 Mar; 47(1):83-87. PubMed ID: 28569290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in renal disease: causes, consequences and treatment.
    Mesquita J; Varela A; Medina JL
    Endocrinol Nutr; 2010 Nov; 57(9):440-8. PubMed ID: 20850395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dialysis modality and cardiac disease in chronic kidney insufficiency].
    Grzegorzewska AE
    Pol Merkur Lekarski; 2006 Apr; 20(118):453-6. PubMed ID: 16886575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities in the development of therapeutics for chronic kidney disease.
    Shayman JA
    Transl Res; 2015 Apr; 165(4):482-7. PubMed ID: 25218118
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.